CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PubGene AS is developing a comprehensive pipeline for precision cancer medicine, focusing on personalized treatments based on genetic profiling. This approach aims to improve patient outcomes by providing tailored therapies that minimize side effects and enhance treatment efficacy.
Cancer cost the EU €126 billion in 2009, while in 2010 the US spent a staggering $124.6 billion on treating cancer.
This cost is set to rise as the effects of an aging population and increasing life expectancy take their toll.
These market drivers will put an intolerable strain on health services across the western world, forcing governments to streamline their health services.
Current cancer treatment is based on the ""average cancer patient"", meaning some cancer patients may not respond to t…
PUBGENE AS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
